in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance...

why novartis� landmark cancer drug approval is great news for bluebird.

. january 2014  (16).. to see how we safeguard and use the information you provide us with. if your facebook account does not have an attached e-mail address, you'll need to add that before you can sign up.